• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Virol . Antigenic and structural analysis of the influenza hemagglutinin lateral patch

tetano

Editor, Senior Moderator
J Virol

. 2026 Sep 23:e0126526.
doi: 10.1128/jvi.01265-26. Online ahead of print.

Antigenic and structural analysis of the influenza hemagglutinin lateral patch​


Jordan I Lemus-Reyes # 1 , Monica L Fernández-Quintero # 2 , Edgardo Ayala 1 , Olivia M Swanson 2 , Marina R Good 1 , Wei Ji 1 , Devika Suja 1 , Julianna Han 2 , Andrew B Ward 2 , Jenna J Guthmiller 1

Affiliations


Abstract​


The lateral patch epitope of the H1 hemagglutinin (HA) was a dominant target of antibodies following exposure to the 2009 pandemic H1N1 virus. However, the conservation and mechanisms of antigenic drift in the lateral patch remain unresolved. Here, we used lateral patch-specific monoclonal antibodies (mAbs) to understand the antigenicity of the lateral patch of human, avian, and swine H1Nx viruses spanning from 1918 to 2022. We found that lateral patch-specific mAbs demonstrated broad binding to pre-2009 H1N1 viruses and to the pandemic 2009 H1N1. However, we identified discrete mutations that drove multiple antibody evasion pathways for lateral patch-targeting mAbs in post-2009 H1N1 viruses. Despite this, we observed that the lateral patch remains well conserved across enzootic sources, suggesting that existing lateral patch antibodies could protect against a future zoonotic H1Nx pandemic. Together, these data support that the lateral patch remains an attractive target for pandemic preparedness against emergent H1Nx viruses.IMPORTANCESeasonal influenza viruses continually undergo antigenic drift to evade antibody-mediated immunity, yet how individual antibody specificities shape this evolution remains poorly understood. We investigated the conservation and antigenic evolution of the H1 hemagglutinin (HA) lateral patch, an epitope targeted by broadly neutralizing antibodies. Using human monoclonal antibodies, we found that the lateral patch had remained highly conserved across nearly a century of human and animal influenza virus circulation but has undergone antigenic drift multiple times in pre- and post-2009 seasonal H1N1 viruses. Structural and mutational analyses revealed how these substitutions alter antibody recognition and shape the genetic features of lateral patch-targeting antibodies across individuals born in different eras. The lateral patch is also conserved among swine and avian H1Nx viruses, highlighting its potential as a target of protective immunity against pandemic H1Nx viruses. These findings provide a comprehensive framework for understanding antibody-driven evolution within a broadly conserved influenza virus epitope.

Keywords: H1N1; antigenic drift; influenza virus; monoclonal antibodies.
 
Back
Top Bottom